Literature DB >> 5476247

Effects of agents altering vascular calcium in experimental atherosclerosis.

P J Whittington-Coleman, O Carrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5476247     DOI： 10.1016/0021-9150(70)90079-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  4 in total

1.  Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation.

Authors:  R E Clark; I Y Christlieb; T B Ferguson; C S Weldon; J P Marbarger; B E Sobel; R Roberts; P D Henry; P A Ludbrook; D Biello; B K Clark
Journal:  Ann Surg       Date:  1981-06       Impact factor: 12.969

2.  Calcium/calmodulin-mediated action of calcitonin on lipid metabolism in rats.

Authors:  Y Nishizawa; Y Okui; M Inaba; S Okuno; K Yukioka; T Miki; Y Watanabe; H Morii
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

3.  Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

Authors:  D M Kramsch; A J Aspen; C S Apstein
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

4.  Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits.

Authors:  R E Sievers; T Rashid; J Garrett; S Blumlein; W W Parmley
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.